Cefotaxime Sodium Injection Shortage
Last Updated: October 2, 2024
Status: Current
Products Affected - Description
-
- Claforan injection, Baxter, 1 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0038-05 - discontinued
- Claforan injection, Baxter, 2 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0039-05 - discontinued
- Cefotaxime Sodium powder for solution for injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9931-25
- Cefotaxime Sodium powder for solution for injection, Hikma, 10 gram, vial, 1 count, NDC 00143-9935-01
- Cefotaxime Sodium powder for solution for injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9933-25
- Cefotaxime Sodium powder for solution for injection, Hikma, 500 mg, vial, 10 count, NDC 00143-9930-10
Reason for the Shortage
-
- Hospira has discontinued Claforan. Sanofi-Aventis manufactured Claforan for Hospira and is no longer making the product.
- Hikma is not currently marketing cefotaxime injection.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Provepharm is temporarily importing cefotaxime 1 gram and 2 gram vials.
Alternative Agents & Management
-
- FDA is allowing temporary importation of cefotaxime 1 gram and 2 gram vials from Provepharm and its distributor Direct Success. The cefotaxime is supplied by SteriMax from Canada. Customers can contact Direct Success at 1-877-404-3338 to place orders. See https://www.fda.gov/media/152806/download for details.
Updated
Updated October 2, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 31, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.